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African horsesickness (AHS) is a devastating disease of horses. The disease is caused by the double-stranded RNA-containing
African horsesickness virus (AHSV). Using electron cryomicroscopy and three-dimensional image reconstruction, we deter-
mined the architecture of an AHSV serotype 4 (AHSV-4) reference strain. The structure revealed triple-layered AHS virions en-
closing the segmented genome and transcriptase complex. The innermost protein layer contains 120 copies of VP3, with the viral
polymerase, capping enzyme, and helicase attached to the inner surface of the VP3 layer on the 5-fold axis, surrounded by dou-
ble-stranded RNA. VP7 trimers form a second, T13 layer on top of VP3. Comparative analyses of the structures of bluetongue
virus and AHSV-4 confirmed that VP5 trimers form globular domains and VP2 trimers form triskelions, on the virion surface.
We also identified an AHSV-7 strain with a truncated VP2 protein (AHSV-7 tVP2) which outgrows AHSV-4 in culture. Compari-
son of AHSV-7 tVP2 to bluetongue virus and AHSV-4 allowed mapping of two domains in AHSV-4 VP2, and one in bluetongue
virus VP2, that are important in infection. We also revealed a protein plugging the 5-fold vertices in AHSV-4. These results shed
light on virus-host interactions in an economically important orbivirus to help the informed design of new vaccines.
African horsesickness (AHS) is a noncontagious, infectious,arthropod-borne viral disease of equids, such as horses and
donkeys, that is caused by African horsesickness virus (AHSV)
(65). The AHS mortality rate is over 90% in fully susceptible
horses (those that have not been exposed to any virus subtype
previously), although zebra and African donkeys rarely show clin-
ical signs (16). AHS is endemic to sub-Saharan Africa and the
Arabian Peninsula but has periodically caused epidemics in other
areas, such as India, Pakistan, Spain, and Portugal (12, 30, 36, 47,
49, 57). The vectors for AHSV are certain species of biting midges
in the genus Culicoides. Based on the vector’s feeding preference
for larger mammals, including horses, wide geographical distribu-
tion, and relative abundance in light trap collections, Culicoides
(Avaritia) imicola Kieffer is considered the most important vector
of AHSV in South Africa (45, 69). Oral susceptibility studies cou-
pled to the isolation of AHSV from field-collected midges have
also implicated Culicoides (Avaritia) bolitinos Meiswinkel as a po-
tential vector in South Africa (42, 47, 69). The geographical dis-
tribution and seasonal incidence of AHS are thus largely deter-
mined by the presence of competent Culicoides vectors.
In South Africa, AHSV is transmitted by the same insect vec-
tors as those that transmit bluetongue virus (BTV). The presence
and spread of BTV in Europe increase the probability that out-
breaks of AHS will follow (43, 44, 46, 48, 56, 66). AHS is a World
Organisation for Animal Health (OIE)-listed disease, which
means that the movement of horses from affected areas is tightly
controlled, causing an economic burden on the equine industry in
affected countries. A better understanding of the structure and life
cycle of AHSV and the mechanisms that control infection in both
its insect and equid hosts would inform work on disease control
and the development of rationally designed vaccines.
AHSV is a nonenveloped, icosahedrally symmetric virus with a
genome composed of 10 linear segments of double-stranded RNA
(dsRNA) (5, 53). The species African horsesickness virus is classi-
fied as a member of the genus Orbivirus, within the family Reoviri-
dae. There are nine AHSV serotypes (AHSV-1 to AHSV-9) (31,
41). The outer capsid protein VP2 determines the serotype and
can induce a protective immune response (7, 10, 39, 62). Eight of
the 10 AHSV genome segments code for a single protein (5, 6, 23).
There are four nonstructural proteins (NS1, NS2, NS3/3A, and
NS4), involved in virus replication, morphogenesis, and release
from the infected cell (3, 17, 61, 67, 68). Little is known about the
role of NS1 in AHSV replication.
The AHSV particle contains seven structural proteins (VP1 to
VP7) arranged as three concentric layers surrounding the genome
(5, 6, 23). Only the structure of a proteolytic fragment of VP7 has
previously been reported for AHSV (2). The first atomic structure
of any orbivirus, that of the BTV 1 core, revealed the organization
of the genome and the two innermost layers of the capsid (14, 20,
22). The dsRNA is covered by a shell of 60 asymmetric dimers of
VP3, as also seen, for example, in reovirus, rotavirus, L-A virus,
and members of the Cystoviridae (11, 32, 34, 50, 58, 73). The
minor proteins VP1 (polymerase), VP4 (capping enzyme), and
VP6 (helicase) form a flower-like transcriptase complex under the
5-fold vertices (51, 61). VP3 is covered by 260 trimers of VP7,
organized as a T13 lattice (14, 20, 22). It has been shown by
electron cryomicroscopy (cryo-EM) and image reconstruction
that the outermost layer of the BTV virion is formed by the major
structural proteins VP2 and VP5, forming triskelions (trimers of
VP2) and globular domains on top of VP7 (27, 51, 72). The BTV
VP2/VP5 layer mediates cell attachment and entry, determining
the replication site of the virus and its cell tropism (18, 19, 25, 26,
70, 72). Although VP2 is believed to mediate the initial cell attach-
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ment, VP5 contains coiled-coil motifs typical of membrane fusion
proteins and is thought to play a role in membrane penetration
during cell entry (72).
In this study, we examined AHSV-4 and AHSV-7 tVP2 virions.
AHSV-7 tVP2 was shown to have a truncated VP2 protein caused
by a deletion in genome segment 2. AHSV-7 tVP2 outgrew the
AHSV-4 strain during infection and replication in mammalian
cell cultures. We used sequence and structural comparisons of
AHSV-4, AHSV-7, and BTV, based on cryo-EM, three-dimen-
sional (3D) reconstruction, and homology modeling, to describe
the structure of AHSV and to map two domains in the VP2 struc-
ture.
MATERIALS AND METHODS
Virus propagation and purification. The AHSV-4 strain was derived
from the OIE reference strain AHSV-4 HS32/62 (16). A freeze-dried stock
of the virus was plaque cloned on Vero cells. The AHSV-7 strain was
plaque purified from a stock of AHSV-6 (HS39/63) during characteriza-
tion of stocks for large-scale sequencing and is referred to as AHSV-7
tVP2. AHSV-4 and AHSV-7 tVP2 were produced on BHK-21 cell mono-
layers and purified on sucrose gradients as previously described (33). Vi-
rus was used directly, or samples were lyophilized for storage in 2% (wt/
vol) sucrose, 2 mM Tris-HCl, pH 8.5. Purified virus was resuspended in 2
mM Tris-HCl, pH 8.5, at a concentration of 200 g/ml for AHSV-4 and 50
g/ml for AHSV-7 tVP2.
Sequencing of AHSV-4 and AHSV-7 tVP2. Extraction of dsRNA
from purified virus, sequence-independent genome amplification, high-
throughput sequencing, and sequence assembly were performed as de-
scribed previously (55), using 454 sequencing (Inqaba Biotec, Pretoria,
South Africa). Sequence comparison was carried out with online servers
for Clustal W for multiple-sequence alignments (21, 35) and with
EMBOSS Needle for pairwise alignments (52).
Growth competition experiments between AHSV-4 and AHSV-7
tVP2. A growth competition experiment was set up between AHSV-4 and
AHSV-7 tVP2 to see if one of the viruses would outgrow the other. Both
viruses were titrated on Vero cells and the stocks diluted to 105 50% tissue
culture infective doses (TCID50) per ml. The stocks were then mixed at
ratios of 1:1, 1:10, and 1:100 of AHSV-7 tVP2 to AHSV-4 before infecting
Vero cells. The virus mixtures were passaged three times consecutively in
Vero cells. Each time, the cells were left until all the cells showed cyto-
pathic effects. After each passage, the cells were harvested, and viral
dsRNA was extracted, purified, separated in a 1% agarose gel in Tris-
borate-EDTA (TBE) buffer, and stained with ethidium bromide as de-
scribed previously (55).
Electron cryomicroscopy. Samples were prepared by vitrification of
3-l aliquots of either fresh or lyophilized and rehydrated virus on Quan-
tifoil R 2/2 holey carbon-coated copper grids as previously described (1).
Specimens were held in a Gatan 626 cryoholder maintained at 180°C for
imaging in an FEI Tecnai F20 microscope (University of Cape Town)
operated at 200 kV under low-dose conditions. Single images were re-
corded on Kodak SO 163 film at a nominal magnification of 50,000
(AHSV-4 and empty AHSV-7 tVP2) or on a Gatan Ultrascan 4000 charge-
coupled device (CCD) camera at a magnification of 83,000 (filled
AHSV-7 tVP2). The film was developed in full-strength Kodak D19 de-
veloper for 12 min (63).
Image processing. The negatives were digitized using a Zeiss Photo-
scan TD scanner with a 7-m step size and were binned to 14 m. The
sampling was done at 0.28 nm/pixel on film and 0.18 nm/pixel by the CCD
camera. Micrographs were processed as described previously (63), and the
orientations were determined and reconstructions calculated by imposing
full icosahedral symmetry using AUTO3DEM (71). The resolution of the
reconstructions was estimated by calculating the Fourier shell correlation
to 0.5 between two half data sets (24). Visualization and segmentation of
the densities were carried out with the UCSF Chimera package (54).
Difference maps between AHSV-4, AHSV-7 tVP2, and BTV 1 (72)
were generated in Robem, which is part of the AUTO3DEM package (71).
Prior to difference imaging, a low-pass filter with a Gaussian edge was
applied to all the reconstructions, using the Bsoft operation bfilter (29) to
cut off information beyond 15.8 Å, the calculated resolution of the
AHSV-7 tVP2 reconstruction (Table 1).
Modeling of AHSV-4. Structural homology modeling tools were used
to make predictions for all of the structural proteins of AHSV-4. The
predicted amino acid sequences were submitted to the I-TASSER server
(59, 74). Only VP3 and VP7 gave high C scores (0.53 and 1.87, respec-
tively, where the values can range from 5 to 2), indicating models with
high confidence (59, 74). These homology models were used to generate
an icosahedrally symmetric model of the AHSV-4 core. The BTV X-ray
structure of either the VP3 dimer or one monomer of VP7 from the
atomic model of the BTV core (RCSB Protein Data Bank [PDB] accession
number 2btv) (22) was used to align the corresponding AHSV-4
I-TASSER model, using the Chimera Matchmaker command (54). The
resulting pdb file was submitted to the Viperdb oligomer generator to
make a pseudoatomic model of the virion core (9). This model was used to
disclose the positions of the major proteins VP2 and VP5 and the minor
proteins VP1, VP4, and VP6 in Chimera (54).
Accession numbers. The nucleotide sequences obtained in this study
were submitted to GenBank under the following accession numbers: for
AHSV-7 tVP2, JQ742006, JQ742007, JQ742008, JQ742009, JQ742010,
JQ742011, JQ742012, JQ742013, JQ742014, and JQ742015; and for
AHSV-4, JQ796724, JQ796725, JQ796726, JQ796727, JQ796728,
JQ796729, JQ796730, JQ796731, JQ796732, and JQ796733. The virus re-
constructions were deposited in the EMDB database under accession
numbers EMD-2075, EMD-2076, and EMD-5412.
RESULTS
The AHSV-4 strain used here came from a plaque from a 1962
field isolate. AHSV-7 tVP2 is a plaque isolate that has a truncated
VP2 protein and was identified during large-scale sequencing ef-
forts with AHSV strains at ARC-Onderstepoort Veterinary Insti-
tute (ARC-OVI). The dsRNAs of both AHSV-4 and AHSV-7 tVP2
were isolated, and AHSV-7 tVP2 was shown to have a shorter
genome segment 2 than those of other AHSV isolates, including
AHSV-4 (Fig. 1). Sequencing of genome segment 2 cDNA pre-
pared from the isolate showed that there was an in-frame deletion
of the coding region for 225 amino acids in VP2 (residues 279 to
503 are missing). We demonstrated that this deletion in genome
segment 2 conveys a competitive advantage on AHSV-7 tVP2 cul-
tured in Vero cells through a growth competition assay where
AHSV-4 and AHSV-7 tVP2 were mixed either in equal amounts
or with a 10- or 100-fold excess of AHSV-4. In all three cases, after
three passages, the AHSV-7 tVP2 strain was dominant as judged
by the extracted RNA profile (Fig. 1). Both viruses were purified,
and the viral proteins were analyzed by SDS-PAGE. As expected,
VP2 from AHSV-7 tVP2 migrated faster than that from AHSV-4,
and it can be seen below AHSV-7 tVP2 VP3 on the gel. The profiles
for the other viral proteins were very similar (Fig. 2). This natu-










AHSV-4 307 1,633 0.8-5.8 14.4
Empty AHSV-7
tVP2
70 361 0.7-4.3 15.8
Filled AHSV-7 tVP2 507 2,798 0.8-4.4 11.4
a Fourier shell correlation cutoff of 0.5 (24).
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rally occurring truncation was a useful tool in our structural anal-
yses. The predicted amino acid sequences of AHSV-4 VP3 and
VP7 were used for homology modeling (59, 74).
We analyzed purified samples of AHSV-4 and AHSV-7 tVP2
virus particles by cryo-EM and 3D image reconstruction. The
electron micrographs showed that most of the particles from fresh
preparations of AHSV-7 tVP2 and AHSV-4 were RNA filled,
spherical, and intact, with a diameter of approximately 87 nm
(Fig. 3A). The lyophilized samples (AHSV-4 and AHSV-7 tVP2)
contained mostly viral particles that had lost the genome, but
otherwise they seemed intact (Fig. 3B). Long helical tubules of the
nonstructural viral protein NS1, which copurifies with AHSV,
were also seen in many of the micrographs (data not shown),
similar to those reported for BTV (28).
Reconstructions were calculated from fresh and lyophilized
virion preparations, separating the particles into those that were
RNA filled and those that were empty. The data sets are summa-
rized in Table 1. The icosahedrally symmetric reconstructions re-
vealed a triple-layered structure encapsidating the 10 dsRNA
genomic segments (Fig. 3C and D), as illustrated schematically in
Fig. 3E and F. The AHSV-4 and AHSV-7 tVP2 reconstructions are
very similar to each other (Fig. 3 to 5). There are three main dif-
ferences, in the presence of RNA, in the vertices, and in the triske-
lions. The AHSV-7 tVP2 reconstruction from lyophilized particles
lacks the RNA and thus reveals the position of a transcription
complex near each of the 5-fold vertices (Fig. 3D, right-hand side,
and 6A). The AHSV-7 tVP2 vertices are nonoccluded at the level
of VP5 (Fig. 3D and F, 4B and C, and 5K and L), as seen, for
example, in BTV (72). However, in AHSV-4, they are occluded by
a spherical, poorly defined density (Fig. 3C and E, 4A, and 5G and
H). As predicted by the sequencing and protein profiles, the triske-
lions on the surface of AHSV-4 are considerably larger than those
on AHSV-7 tVP2 (Fig. 3C and D, 4, and 7). The VP2 and VP5
layers in both AHSV-4 (mixture of fresh and lyophilized virus)
and empty AHSV-7 tVP2 (mainly lyophilized virus) reconstruc-
tions appear to have weaker density than that of the VP7 and VP3
layers. We attribute this to partial occupancy of VP2 and VP5,
caused by a decrease in the particle structural integrity after lyoph-
ilization and rehydration.
The innermost shell of AHSV is a T1 lattice of 60 asymmetric
dimers of VP3, which is a flat, approximately triangular molecule
of about 103 kDa (Fig. 5A, E, and I and 6A, B, D, and F). The 58%
amino acid sequence identity between BTV 1 and AHSV-4 VP3
proteins (Table 2) allowed us to generate homology models for the
AHSV-4 VP3 A and B monomers and to align them against BTV
VP3 (22, 59, 74). The structures matched very well (root mean
square deviations [RMSD] of the -carbon backbone of 0.2 and
0.3 Å, respectively), with the only difference being the presence of
an extra loop and a helix from residues 1 to 59 at the N terminus of
the AHSV-4 VP3 A monomer. These homology models were used
to generate an icosahedrally symmetric shell that fitted well into
the EM density, apart from the first 100 residues of the AHSV-4
VP3 A monomer, indicating that the homology model may be
unreliable in this region (Fig. 6F). This is not very surprising, as
residues 1 to 56 are missing in the BTV VP3 A monomer atomic
model (22), although they were subsequently modeled at low res-
olution as a chain of density interacting with the transcriptase
complexes sitting near each of the 5-fold symmetry axes (20). To
be conservative, we removed the first 100 amino acids from the
AHSV-4 VP3 A monomer homology model (Fig. 6D). The RNA-
filled AHSV-7 tVP2 map shows three well-ordered layers of RNA
under VP3 (Fig. 3D, asterisks), surrounding the transcription
FIG 1 Growth competition in tissue culture between AHSV-4 and AHSV-7 tVP2. Virus stocks of AHSV-4 and AHSV-7 tVP2 were mixed at different ratios and
passaged three times in Vero cells. RNAs were extracted, purified, separated in a 1% agarose gel, and stained with ethidium bromide. Lane 1, AHSV-4 dsRNA; lane
2, AHSV-7 tVP2 dsRNA; lane 3, marker; lane 4, 1:1 ratio of AHSV-7 tVP2 to AHSV-4, passage 1; lane 5, 1:1 mixture, passage 2; lane 6, 1:1 mixture, passage 3; lane
7, marker; lane 8, 1:10 ratio of AHSV-7 tVP2 to AHSV-4, passage 1; lane 9, 1:10 mixture, passage 2; lane 10, 1:10 mixture, passage 3; lane 11, marker; lane 12, 1:100
ratio of AHSV-7 tVP2 to AHSV-4, passage 1; lane 13, 1:100 mixture, passage 2; lane 14, 1:100 mixture, passage 3. Genome segments visible on the gel are labeled
1 to 10 in lane 1. The arrow in lane 2 indicates the position of AHSV-7 tVP2 genome segment 2.
FIG 2 SDS-PAGE analysis of purified AHSV-4 and AHSV-7 tVP2 virions.
Virion proteins are marked on the gel, along with the nonstructural protein
NS1, which copurified with the virions. A molecular weight standard is shown
in lane 1. Comparison of AHSV-4 (lane 2) and AHSV-7 tVP2 (lane 3) clearly
shows the difference in molecular weight for VP2.
Manole et al.
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complexes. The spacing between the ordered RNA layers is 3 nm.
There are shallow grooves in the inner surface of BTV VP3, along
which RNA can move, and these were also seen in the AHSV
reconstructions and homology models (20, 22). Although the
dsRNA genome is organized as 10 unique linear segments, the
individual segments were icosahedrally symmetrized during
the reconstruction, thus smearing the density and making them
indistinguishable.
The next capsid shell, representing the surface layer of the
AHSV core particle, is composed of 780 monomers of VP7 (38
kDa), arranged as 260 trimers on a T13 lattice (Fig. 5B, F, and J
and 6A, C, and G). A homology model of the full-length AHSV-4
VP7 monomer (an X-ray structure is available for the top domain
[2]) was generated with very high confidence and an RMSD com-
pared to BTV of 0.5 Å (Fig. 6E), which fitted well into the corre-
sponding EM density for all three reconstructions (Fig. 6).
The outermost layer of the virion (Fig. 3, 4, 5D, H, and L, and
7; also see Fig. 8) is formed by the major structural proteins VP5
(57 kDa) and VP2 (124 kDa for AHSV-4). The major difference in
FIG 3 Overall organization of AHSV. (A) Cryo-electron micrograph of
AHSV-4, taken with a 1.0-m underfocus, showing intact viral particles of 87
nm in diameter (black arrows). (B) Cryo-electron micrograph of lyophilized
AHSV-7 tVP2, taken with a 1.8-m underfocus, showing intact viral particles
(black arrow) and ones devoid of RNA (white arrows). Bar, 100 nm. (C)
Central cross section through the AHSV-4 reconstruction (0.28 nm thick).
Twofold (ellipse), 3-fold (triangle), and 5-fold (pentagon) axes of symmetry
are indicated. (D) Central cross section through the AHSV-7 tVP2 reconstruc-
tions from filled (left; 0.18 nm thick) and empty (right; 0.28 nm thick) parti-
cles. Three well-ordered layers of RNA (white asterisks) are indicated. Bar, 25
nm. Proteins are black. (E and F) Schematic organization of AHSV-4 (E) and
AHSV-7 tVP2 (F), showing genomic RNA segments (forest green strands) and
polymerase complexes (dark blue) enclosed by VP3 (cyan). Trimers of VP7
(green) attach to the surface of VP3. Trimers of the serotype determinant VP2
(purple) sit directly on top of VP7, with VP5 trimers (yellow) filling the spaces
of the VP2 lattice. The AHSV-4 virion has additional density on the surface,
from an unidentified protein (pale blue circles in panel E).
FIG 4 Radially depth-cued isosurface representations of the reconstructions,
viewed down a 2-fold axis of symmetry. The isosurfaces were drawn at 1 
above the mean density level. The structures were radially depth cued in Chi-
mera (54). (A) AHSV-4 at 14.4-Å resolution; (B) empty AHSV-7 tVP2 at
15.8-Å resolution; (C) filled AHSV-7 tVP2 at 11.4-Å resolution. The radial
depth-cueing scale bar shows scale in nm. Fivefold (pentagon), 3-fold (trian-
gle), and 2-fold (ellipse) symmetry axes are marked on each representation.
AHSV Structure
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the reconstructions between AHSV-4 and AHSV-7 tVP2 is the size
of the triskelions that are centered directly on top of the VP7 Q
trimer (22, 72). These 60 triskelions, formed from 180 copies of
VP2, are much smaller in AHSV-7 tVP2 (Fig. 3, 4, and 7). By
amino acid sequence comparison of 24 related proteins from
AHSV, BTV, and epizootic hemorrhagic disease virus, it was pos-
sible to align the deletions in AHSV-7 tVP2 and BTV 1 with the
AHSV-4 sequence (Fig. 7A; see Fig. S1 in the supplemental mate-
rial). VP2 is the least conserved among the AHSV and BTV struc-
tural proteins (Table 2); for example, there is only 40% identity in
this protein between AHSV-4 and AHSV-7 tVP2 in a pairwise
alignment, with only 17% identity between AHSV-4 and BTV 1
(52). Since VP2 is the major immunogen, it is highly variable due
to selective pressure from the host immune system. Thus, we car-
ried out superimpositions of the VP2 triskelions from AHSV-4,
AHSV-7 tVP2, and BTV 1 to identify approximately where amino
acids 279 to 503 lie in the AHSV-4 VP2 3D structure. Two main
differences were seen, one in the tips (tip domain) and the other in
the center of the triskelion (central domain) (Fig. 7E and F). The
central domains are lacking from both BTV 1 and AHSV-7 tVP2
VP2 molecules, as can be seen in Fig. 7C and F. One domain
presumably comes from one VP2 monomer. Each central domain
thus corresponds approximately to VP2 residues 368 to 483 in
AHSV-4 (Fig. 7A). The distal tips of the triskelions are lacking only
from AHSV-7 tVP2. This difference is evident when AHSV-7
tVP2 is compared to either AHSV-4 or BTV 1 (Fig. 7C, D, F, and
G). This tip density thus comes primarily from residues 279 to 368
in AHSV-4 (Fig. 7A). Hence, the triskelion wings are positioned in
the N-terminal direction from the central domain.
VP5 is a globular trimeric protein positioned in two different
environments, i.e., between the peripentonal VP2 molecules and
around VP7 on the 3-fold axis of symmetry (Fig. 4 and 5C, G, and
K). In both environments, VP5 is in close proximity to VP2. It is
predicted to be mainly -helical (data not shown). Comparison of
VP5 proteins segmented from the BTV 1 and AHSV-7 tVP2 re-
constructions (72) indicated that AHSV VP5 is very similar to that
of BTV 1 in shape, and probably also in fold topology, even though
it was not possible to make a reliable homology model of AHSV
VP5 to confirm this independently (Fig. 8).
DISCUSSION
AHS is endemic to the African continent, and due to recent events
with BTV, it is considered a potential threat to horses in southern
Europe. It has previously caused outbreaks in Spain (1987 to
1990) and Portugal (1989), causing major economic losses in the
equine industry (12, 47). We have determined the sequences and
architecture of AHSV-4 and AHSV-7 tVP2, belonging to the ge-
nus Orbivirus in the family Reoviridae, using cryo-EM and 3D
image reconstruction. We observed marked structural similarities
between AHSV and BTV (the type species of the family), especially
in their core particles (14, 20, 22, 72). This helped in interpreting
the AHSV data.
FIG 5 Comparison of protein layers within the structures of AHSV-4 and AHSV-7 tVP2, looking down a 3-fold axis of symmetry. (A) Three molecules of VP3
from AHSV-7 tVP2 are shown at a threshold of 1  above the mean. The density was cut out using a 12-Å zone radius around the homology model of a VP3 trimer
fitted into the density in Chimera (54). (B) AHSV-4 shown at a threshold of 3.2  above the mean so that the organization of the green VP7 trimers is evident.
(C) AHSV-4 shown at a threshold of 2.5  above the mean so that the organization of VP7 with the intervening VP5 trimers (yellow) sitting on the quasi-6-fold
axes of symmetry (indicated with black asterisks in panels B and C) is evident. (D) AHSV-4 shown at a threshold of 1  above the mean so that the organization
of VP2 (red) is evident. (E to L) Radial shells of the AHSV-4 and AHSV-7 tVP2 reconstructions. Proteins are black. (E to H) AHSV-4; (I to L) AHSV-7 tVP2. (E
and I) VP3 layer at 26.2-nm radius; (F and J) VP7 trimers visible at 29.4-nm radius; (G and K) VP5 trimers visible at 35.3-nm radius, where the additional density
plugging the 5-fold vertices in AHSV-4 is obvious compared to the case in AHSV-7 tVP2, which has holes on the 5-fold vertices; (H and L) VP2 triskelions at
38.9-nm radius.
Manole et al.
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Homology modeling and fitting of AHSV-4 VP7 and the asym-
metric dimer of VP3 indicated that the inner core has a similar
topology to that of BTV 1 (22). The AHSV-4 and AHSV-7 tVP2
VP3 layers were closed at their 5-fold vertices, preventing the es-
cape of nascent RNA, which is thought to exit through there dur-
ing active transcription in BTV (14, 22). In addition, AHSV-4 had
an additional density blocking the 5-fold vertices at the level of the
VP5 shell. This protein is probably incorrectly 5-fold averaged or
flexible, as the structure does not show the same level of detail for
this protein as for the rest of the proteins. Given the size of this
density, it could be a trimer of VP5 which has been smeared by
5-fold averaging applied during the reconstruction process, or it
could be part of VP2 from the surrounding triskelions.
VP2 is the major determinant of the immune response to
AHSV, raising neutralizing antibodies in infected or vaccinated
animals (10, 15, 39, 60, 62, 64). As such, it is subject to selective
pressure from the equid host, yet it must maintain its function
(and thus structure), as it plays a critical role in the initial steps of
FIG 6 Modeling of VP3 and VP7. (A) Slabbed isosurface representation of the AHSV-7 tVP2 empty-particle reconstruction, rendered at 1  above the mean with
the fitted homology models of VP3 (cyan and red string) and VP7 (blue string). The densities correspond very well. The transcription complexes can be seen as
protruding lumps of density beneath VP3 penetrating into the interior of the capsid. (B) Homology model of the VP3 shell, containing 120 molecules in a T1
arrangement. The two copies of VP3 within one asymmetric unit are colored cyan and red. (C) Homology model of the VP7 shell, containing 780 molecules in
a T13 arrangement. The asymmetric unit contains 13 copies of VP7. The 5 trimers (P, Q, R, S, and T) contributing to the asymmetric unit are colored yellow,
green, blue, purple, and red, respectively (nomenclature according to reference 22). Trimer T sits on an icosahedral 3-fold axis, so it contributes only one
monomer to the asymmetric unit. (D) Superposition of the AHSV-4 VP3 A monomer homology model on the BTV VP3 A monomer (22), using ribbon
representation. (E) Superposition of the AHSV-4 VP7 homology model on the BTV VP7 A monomer (22), using ribbon representation. AHSV-4 VP3 and VP7
are colored from the N terminus (blue) to the C terminus (red), according to amino acid sequence. BTV VP3 and VP7 are presented as gray ribbons. (F)
Homology model of a VP3 dimer (cyan and red) fitted into the EM density of the VP3 shell from filled AHSV-7 tVP2 (gray isosurface), shown at a threshold of
1.7  above the mean. The density was cut out using a 20-Å zone radius around the homology model, using Chimera (54). (G) Homology model of a VP7 trimer
(magenta) fitted into the EM density of the VP7 layer from empty AHSV-7 tVP2 (gray isosurface), shown at a threshold of 1.9  above the mean, from the top
and from the side. The density was cut out using a 14-Å zone radius around the homology model, using Chimera (54).
AHSV Structure
August 2012 Volume 86 Number 15 jvi.asm.org 7863



































infection. VP2 is sensitive to equine serum proteases, which in-
crease the infectivity of the virus in Culicoides variipennis (8, 38). It
is highly likely that VP2 endoproteolytic cleavage can also occur in
the saliva of the insect host, as has been demonstrated for BTV
(13). Thus, VP2 activation could play a crucial role in virus entry
in vivo, as a host specificity determinant. Hence, knowledge of VP2
structure and changes occurring in VP2 that affect infectivity is
important in guiding the development of possible vaccines (10).
We report an AHSV-7 strain that has a deletion of 225 amino
acids (residues 279 to 503) in VP2 compared to AHSV-4 VP2, in a
region that is known to contain immunogenic epitopes (4, 39).
Amino acids 340 to 360 have been implicated in determining tis-
sue tropism and virulence (55). Here we demonstrated that the
AHSV-7 tVP2 strain outgrows AHSV-4 in tissue culture and also
FIG 7 Mapping of deletions in VP2. (A) Schematic showing the positions of the major deletions in AHSV-7 tVP2 and BTV 1 compared to AHSV-4 obtained from
a multiple-sequence alignment (see Fig. S1 in the supplemental material). Numbers indicate amino acid residues according to the AHSV-4 sequence. (B and E)
Superposition of VP2 proteins from AHSV-4 (gray transparent density) and BTV (radially depth-cued density), from the top (B) and from the side (E). The main
additional density in AHSV-4 is in the center of the triskelion on top of the hub, coming from residues 368 to 483 in AHSV-4. (C and F) Superposition of VP2
proteins from BTV 1 (gray transparent density) and the empty AHSV-7 tVP2 reconstruction (radially depth-cued density), from the top and from the side. The
main additional density is in the distal end of the triskelion coming from residues 279 to 367 in BTV 1 and AHSV-4. (D and G) Superposition of VP2 from
AHSV-4 (gray transparent density) and AHSV-7 tVP2 (radially depth-cued density), from the top and from the side. The main additional densities are in both
the center and the distal ends of the triskelion coming from residues 279 to 367 and 368 to 483 in AHSV-4.
TABLE 2 Percent identity between amino acid sequences of the viruses











VP1 55.73 55.73 98.39
VP2 17.12 17.06 40.04
VP3 58.02 58.02 99.67
VP4 50.39 50.39 98.60
VP5 42.31 41.56 80.79
VP6 30.08 31.59 62.67
VP7 43.06 42.46 99.71
FIG 8 Comparison of VP5 from the AHSV-7 tVP2 empty-particle reconstruc-
tion and from a BTV-1 reconstruction (72). The VP5 densities were segmented
from their respective reconstructions in Chimera (54). The AHSV-7 tVP2
protein is shown as a gold isosurface, and the BTV protein is shown as a gray
transparent solid (EMDB accession code 5147), with blue wire showing the
C- backbone of VP5 (PDB accession code 3IYK).
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that infected cells show full cytopathic effect faster, implying that
it may have a selective growth advantage. We took advantage of
the shorter VP2 protein to locate the above-mentioned residues in
an AHSV-4 reconstruction by comparison to AHSV-7 tVP2 re-
constructions. We mapped amino acids 279 to 368 onto the
AHSV-4 structure and showed that these immunogenic epitopes
are most probably located on the tips of the VP2 triskelions, free
from interaction with VP5 or VP7 and thus easily subject to mu-
tation (Fig. 7). We also roughly mapped the other major immu-
nogenic residues of AHSV-4 VP2 (amino acids 368 to 403 and 450
to 483) (4) to the top of the triskelion hub (central domain in Fig.
7B, E, D, and G). It is likely that the actual central domain is made
of fewer residues than this. We propose that the central domain is
a good potential target for the horse serum protease (8, 38), as it
sits on top of the putative sialic acid binding site identified in the
BTV 1 hub (72). It is absent from both BTV 1 and AHSV-7 tVP2;
hence, increased accessibility to the putative receptor binding site
could explain the observation of faster growth of AHSV-7 tVP2
than of AHSV-4. In the future, reverse genetics should be applied
to make specific deletions in this region in an otherwise homoge-
neous background to test this hypothesis (40).
Secondary structure prediction of AHSV VP5 indicates that
this mainly -helical protein has an N-terminal amphipathic
helical region (residues 1 to 41 in AHSV-4) (data not shown)
which is a potential fusion peptide (37). Thus, one likely series of
events for cell entry of the virion is as follows: proteolytic cleavage
of VP2 in the serum or in midge saliva, interaction with the host
cell receptor, entry through an endocytic pathway, low-pH acti-
vation of VP5 leading to exposure of the fusion peptide and its
insertion into the endosomal membrane, and release of the dou-
ble-shelled core into the cytoplasm, as suggested for BTV (18,
19, 72).
In conclusion, the AHSV structures are the starting point for a
fuller understanding of the interaction of VP2 with host cells and
the effects of host-driven evolution of the virus to escape the im-
mune responses of both midges and horses. This is extremely im-
portant for the development of better, more efficient vaccines. In
the future, reverse genetics, an atomic model of VP2, mapping of
the serum protease sites, and detailed cell biological studies to
ascertain the routes of infection into the cell will all no doubt
contribute to developments in this field.
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